Philips provides update on its performance trajectory and strategy to capture the opportunities in the HealthTech market at its CMD. + andere beric

Alleen voor leden beschikbaar, wordt daarom gratis lid!

Algemeen advies 15/09/2015 08:39
London, UK – Royal Philips (NYSE: PHG, AEX: PHIA) today will discuss its strategy to capture the attractive opportunities in the growing HealthTech market at its Capital Markets Day in London.

“Last year, we announced our plan to create two leading, fit-for-purpose companies, focused on the HealthTech and Lighting opportunities and today I am pleased to say that we are well on track,” said CEO Frans van Houten. “In Lighting, we are reinforcing our global leadership position and driving attractive financial returns by optimizing our strong position and performance in conventional lighting to fund continuing profitable growth in LED, Systems and Services. In the HealthTech market, we are leveraging our leadership positions to generate higher growth and scale benefits, focusing on integrated solutions along the health continuum based on our advanced technology and deep customer insights.”

During the meeting, CEO Frans van Houten and CFO Ron Wirahadiraksa will also provide an update on the separation process and on the Group’s financial performance trajectory.

“We continue to expect modest sales growth for 2015 and are focused on improving the adjusted EBITA margin, underpinned by better operational performance, despite a less favorable foreign exchange environment and deteriorating market conditions in certain emerging markets, most notably China,” said Frans van Houten. “The underlying strength of our businesses is enabling us to deliver further improvements, and we expect an adjusted EBITA margin in 2016 of around 11%. At the same time, macro-economic risks are increasing and, as a result, we expect modest sales growth in 2016. Separation and restructuring costs are expected to impact profitability by approximately 200 basis points in 2016, resulting in an anticipated reported EBITA margin of around 9% in 2016. The return on invested capital is expected to be more than 12% in 2016.”

As of the first quarter of 2016, Philips intends to move to a new reporting structure. Sales and profitability per reporting segment (four segments in HealthTech, one for Lighting) will be provided on a quarterly basis. Philips intends to provide historical pro-forma comparable numbers under the new reporting structure prior to the publication of the first quarter 2016 results.

Presentations in London will start at 10:00 AM CET. The plenary sessions until around 11:45 AM CET can be followed via a live webcast. A video summary of the subsequent break-out sessions will be made available soon after the end of the event. Please click on this link to follow the webcast and download the slides that will be used during the day.

tijd 09.00
De AEX 428.70 +0,82 +0,19% Philips EUR 22,85 +28ct vol. 113.000

Philips and Dutch Radboud university medical center introduce first diabetes prototype app with integrated online community to empower patients and enhance continuity of care.
Next generation virtual community connects consumers to healthcare providers and allows them to share both consumers' personal health data and healthcare organization’s clinical data
• Via mobile app, patients can track blood glucose levels, insulin use, nutrition, physical activity, mood and stress and get data-driven feedback and coaching guidance* at home and on the go
• Built on the Philips cloud-based HealthSuite digital platform and the Salesforce App Cloud; unveiled at Dreamforce 2015 in San Francisco

San Francisco, CA and Amsterdam, The Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) and Netherlands-based Radboud university medical center (Radboudumc) today introduced a connected digital health prototype that enables people living with diabetes and their health care providers to make more confident care decisions while managing the complexity of diabetes self-care. In its first phase, the solution both organizations are developing will focus on patients living with diabetes type 1.

The system, consisting of a mobile patient app and online community, is the first to collect and connect data from electronic medical records, multiple personal health devices – including wireless glucose meters and activity monitors – and patient self-reported data. Via a smartphone or tablet, the app gives patients continuous access to important parameters such as blood glucose levels, insulin use, and nutrition and provides coaching guidance* at home and on the go. The secure online community is where enrolled patients and healthcare professionals can interact via private messaging or shared posts within a healthcare organization’s clinical guidelines. In this way, patients can get feedback from their care team using the combined data and can easily share experiences with fellow patients, clinicians and caregivers.

The collaborative prototype development among Philips, Radboudumc and Salesforce is available in pilot release by the end of year, with plans to introduce similar connected care solutions addressing other chronic conditions.

Supporting a critical population with a complex condition
Diabetes is a prevalent, chronic condition that is costly in terms of human suffering and global healthcare spending [1] with nearly 400 million people worldwide living with the disease [2]. It is often associated with a variety of other chronic diseases. On average, people with diabetes make up to 180 decisions [3] about their health every day, collecting and evaluating valuable information on personal and medical factors from blood sugar levels to exercise to food choices. The care team of people living with diabetes can add up to more than 10 different types of care providers [4]. This makes living with diabetes complex to self-manage and for many also very stressful.

“I am excited that we are providing people with diabetes the tools to connect all of their relevant health data and devices. Our system allows sharing of data and experiences in one community, where they can collaborate with fellow patients and their care teams in a secure environment,” said Jeroen Tas, CEO Healthcare Informatics Solutions and Services, Philips. “There is a growing need for solutions that enhance self-management and continuity of care for those with chronic conditions such as diabetes to reduce health deterioration, re-admissions and mortality rates. This system has been designed by patients for patients and is enabling fully integrated health management and care delivery in a new, connected, efficient and highly patient-centric way.”

“We want to encourage and support people to take full command of their disease by providing them with the right decision tools. This fits in our mission towards patient-centered participatory health care at Radboudumc,” said Cees Tack, Professor in internal medicine at Radboudumc. “Empowering patients to be true partners in their own health care by giving them access to their data and by facilitating collaboration is the key to driving change across populations,” Lucien Engelen, Director REshape Center at Radboudumc added. “By collaborating with Philips, we’re creating the digital framework necessary to make data actionable and transform how patients engage with their caregivers and social community.”

Enabled by the HealthSuite Digital Platform
The system is built on the Philips HealthSuite digital platform and its new CareCatalyst. This platform securely connects devices and collects, integrates and analyzes patient data from connected consumer and medical devices, electronic medical records, and personal health data. Via this open digital platform, self-measurement sources and overall functionality can easily be extended as new digital health consumer measurement technologies become available. CareCatalyst is a digital toolkit that makes it easy for health systems, institutions and care providers to utilize the power of the HealthSuite digital platform in dedicated localized solutions.

Philips Personal Health Programs to stay healthier and help prevent illness
Further delivering on its commitment to support people throughout the full continuum of health, Philips also recently introduced the first in a series of personal health programs that empower consumers to stay healthier and help prevent illness. Each health program comprises connected health measurement devices, an app-based personalized program and secure, cloud-based data analysis built on the HealthSuite digital platform. Philips personal health programs will empower individuals: to measure vital signs to understand how lifestyle choices affect their body; to set goals and monitor their progress; and to stay motivated with intelligent programs, developed with leading doctors and psychologists, responding to individual progress and making personalized recommendations.

The diabetes prototype system will be presented live by Jeroen Tas and Lucien Engelen at the Dreamforce 2015 conference taking place in San Francisco, Sept. 15-18. For updates on further developments, visit www.philips.com/dreamforce and follow the #DF15 conversation at @PhilipsLiveFrom.

High resolution pictures can be downloaded here.
* Not available in the USA. The app is work in progress and not for medical use. The coaching that is provided should not be construed as medical advice or care. Always consult your qualified personal health care provider before making changes to your medication prescription.

[1] International Diabetes Federation
[2] International Diabetes Federation
[3] Stanford Medicine Scope
[4] Diabetes.org

Salesforce and others are trademarks of salesforce.com, inc.





Beperkte weergave !
Leden hebben toegang tot meer informatie! Omdat u nog geen lid bent of niet staat ingelogd, ziet u nu een beperktere pagina. Wordt daarom GRATIS Lid of login met uw wachtwoord


Copyrights © 2000 by XEA.nl all rights reserved
Niets mag zonder toestemming van de redactie worden gekopieerd, linken naar deze pagina is wel toegestaan.


Copyrights © DEBELEGGERSADVISEUR.NL